BI Asset Management Fondsmaeglerselskab A S Buys 3,625 Shares of Danaher Corporation $DHR

BI Asset Management Fondsmaeglerselskab A S grew its stake in Danaher Corporation (NYSE:DHR) by 13.5% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 30,465 shares of the conglomerate’s stock after acquiring an additional 3,625 shares during the quarter. BI Asset Management Fondsmaeglerselskab A S’s holdings in Danaher were worth $5,776,000 at the end of the most recent quarter.

Other large investors have also recently made changes to their positions in the company. Sivia Capital Partners LLC boosted its position in Danaher by 6.3% during the second quarter. Sivia Capital Partners LLC now owns 2,009 shares of the conglomerate’s stock valued at $397,000 after purchasing an additional 119 shares in the last quarter. First Trust Advisors LP raised its holdings in Danaher by 34.5% in the second quarter. First Trust Advisors LP now owns 55,418 shares of the conglomerate’s stock worth $10,947,000 after purchasing an additional 14,217 shares in the last quarter. Main Street Financial Solutions LLC lifted its position in shares of Danaher by 40.2% during the second quarter. Main Street Financial Solutions LLC now owns 3,088 shares of the conglomerate’s stock valued at $610,000 after buying an additional 886 shares during the last quarter. Ieq Capital LLC lifted its position in shares of Danaher by 64.2% during the second quarter. Ieq Capital LLC now owns 75,714 shares of the conglomerate’s stock valued at $14,957,000 after buying an additional 29,592 shares during the last quarter. Finally, HUB Investment Partners LLC boosted its holdings in shares of Danaher by 30.7% in the 2nd quarter. HUB Investment Partners LLC now owns 1,383 shares of the conglomerate’s stock valued at $273,000 after buying an additional 325 shares in the last quarter. 79.05% of the stock is owned by institutional investors.

Danaher Price Performance

Shares of NYSE:DHR opened at $178.22 on Tuesday. Danaher Corporation has a twelve month low of $160.93 and a twelve month high of $242.80. The company has a current ratio of 1.87, a quick ratio of 1.52 and a debt-to-equity ratio of 0.33. The company has a market cap of $126.14 billion, a PE ratio of 34.47, a price-to-earnings-growth ratio of 2.26 and a beta of 0.81. The company’s 50 day moving average is $179.32 and its 200 day moving average is $202.58.

Danaher (NYSE:DHR) last announced its quarterly earnings data on Monday, April 20th. The conglomerate reported $2.06 EPS for the quarter, beating the consensus estimate of $1.94 by $0.12. The business had revenue of $5.95 billion during the quarter, compared to analysts’ expectations of $6 billion. Danaher had a net margin of 14.89% and a return on equity of 10.91%. The business’s quarterly revenue was up 3.7% compared to the same quarter last year. During the same period in the previous year, the business posted $1.88 EPS. On average, sell-side analysts forecast that Danaher Corporation will post 8.45 EPS for the current year.

Danaher Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be issued a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a dividend yield of 0.9%. The ex-dividend date of this dividend is Friday, June 26th. Danaher’s dividend payout ratio (DPR) is 30.95%.

Analyst Ratings Changes

A number of brokerages have recently issued reports on DHR. Rothschild & Co Redburn set a $205.00 price objective on shares of Danaher in a research report on Friday, April 17th. Piper Sandler initiated coverage on shares of Danaher in a research note on Thursday, June 11th. They issued a “neutral” rating and a $200.00 target price for the company. TD Cowen reduced their price target on Danaher from $245.00 to $240.00 and set a “buy” rating on the stock in a research report on Wednesday, April 22nd. HSBC reduced their price target on Danaher from $270.00 to $230.00 and set a “buy” rating on the stock in a research report on Wednesday, June 3rd. Finally, Wells Fargo & Company lowered their price objective on Danaher from $240.00 to $212.00 and set an “equal weight” rating for the company in a research report on Wednesday, April 22nd. One investment analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have given a Hold rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $233.61.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.